Clenbuterol is a beta-2 adrenergic agonist that has been investigated for its effects on metabolic activity, thermogenesis, and energy expenditure. Originally developed for respiratory applications in certain veterinary settings, it has attracted research interest due to its influence on metabolic pathways and body composition. Clenbuterol is not approved for human use in many jurisdictions and may present significant cardiovascular and other health risks. Ongoing research continues to evaluate its pharmacological properties and safety profile.